Amino acid and albumin losses during hemodialysis. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM (1994) Kidney Int 46: 830-7 Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients. Gupta A, Lin V, Guss C, Pratt R, Ikizler TA, Besarab A (2015) Kidney Int 88: 1187-94 Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Tentori F, Karaboyas A, Robinson BM, Morgenstern H, Zhang J, Sen A, Ikizler TA, Rayner H, Fissell RB, Vanholder R, Tomo T, Port FK (2013) Am J Kidney Dis 62: 738-46 Influence of high-flux biocompatible membrane on carpal tunnel syndrome and mortality. Hakim RM (1998) Am J Kidney Dis 32: 338-40; discussion 340-3 Dialysate ... Ho-hum! Golper TA, Ward RA (2009) Clin J Am Soc Nephrol 4: 1403-4 Technical breakthroughs in the wearable artificial kidney (WAK). Gura V, Macy AS, Beizai M, Ezon C, Golper TA (2009) Clin J Am Soc Nephrol 4: 1441-8 Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis. Clark JA, Schulman G, Golper TA (2008) Clin J Am Soc Nephrol 3: 736-42 Dialysate flow rate and delivered Kt/Vurea for dialyzers with enhanced dialysate flow distribution. Ward RA, Idoux JW, Hamdan H, Ouseph R, Depner TA, Golper TA (2011) Clin J Am Soc Nephrol 6: 2235-9 Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT. Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, Fissell WH (2016) Clin J Am Soc Nephrol 11: 1377-83 Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Connor MJ, Salem C, Bauer SR, Hofmann CL, Groszek J, Butler R, Rehm SJ, Fissell WH (2011) Antimicrob Agents Chemother 55: 557-60 Water treatment for hemodialysis. Ismail N, Becker BN, Hakim RM (1996) Am J Nephrol 16: 60-72 The implantable artificial kidney. Fissell WH, Roy S (2009) Semin Dial 22: 665-70 Measurement and Correlation of Indices of Insulin Resistance in Patients on Peritoneal Dialysis. King-Morris KR, Deger SM, Hung AM, Egbert PA, Ellis CD, Graves A, Shintani A, Ikizler TA (2016) Perit Dial Int 36: 433-41 Dose and adequacy. Golper TA, Twardowski ZJ, Warady BA, Lewy JE, Gotch FA, Firanek C, Eknoyan G (1997) Perit Dial Int 17 Suppl 3: S40-1 Comparison of large volume culture to other methods for isolation of microorganisms from dialysate. Sewell DL, Golper TA, Hulman PB, Thomas CM, West LM, Kubey WY, Holmes CJ (1990) Perit Dial Int 10: 49-52 Backtransport of dialysate solutes during in vitro continuous arteriovenous hemodialysis. Golper TA, Leone M (1989) Blood Purif 7: 223-9 Toward the optimal dose metric in continuous renal replacement therapy. Claure-Del Granado R, Macedo E, Chertow GM, Soroko S, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL (2012) Int J Artif Organs 35: 413-24 Are both creatinine and urea clearances necessary as indices of small solute clearance adequacy in peritoneal dialysis? Tzamaloukas AH, Golper TA (2000) ASAIO J 46: 651-3 Amino acid losses during sustained low efficiency dialysis in critically ill patients with acute kidney injury. Umber A, Wolley MJ, Golper TA, Shaver MJ, Marshall MR (2014) Clin Nephrol 81: 93-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.